Sanara Medtech Stock Today
| SMTI Stock | USD 32.90 0.51 1.57% |
PerformanceVery Weak
| Odds Of DistressLow
|
Sanara Medtech is trading at 32.90 as of the 17th of March 2025. This is a 1.57 percent increase since the beginning of the trading day. The stock's open price was 32.39. Sanara Medtech has about a 21 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 17th of December 2024 and ending today, the 17th of March 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 22nd of February 2011 | Category Healthcare | Classification Health Care |
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas. Sanara Medtech operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. The company has 8.74 M outstanding shares of which 174.18 K shares are at this time shorted by private and institutional investors with about 10.27 trading days to cover. More on Sanara Medtech
Moving together with Sanara Stock
Moving against Sanara Stock
Sanara Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Chairman | Ronald Nixon | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsSanara Medtech can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Sanara Medtech's financial leverage. It provides some insight into what part of Sanara Medtech's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sanara Medtech (SMTI) is traded on NASDAQ Exchange in USA. It is located in 1200 Summit Avenue, Fort Worth, TX, United States, 76102 and employs 107 people. Sanara Medtech is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 283.13 M. Sanara Medtech conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 8.74 M outstanding shares of which 174.18 K shares are at this time shorted by private and institutional investors with about 10.27 trading days to cover.
Sanara Medtech currently holds about 12.68 M in cash with (3.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.53.
Check Sanara Medtech Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Sanara Medtech is $283.13 Million. Sanara Medtech has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 66.75 % of Sanara Medtech outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Sanara Ownership Details
Sanara Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Dimensional Fund Advisors, Inc. | 2024-12-31 | 15.9 K | |
| Squarepoint Ops Llc | 2024-12-31 | 14.8 K | |
| Morgan Stanley - Brokerage Accounts | 2024-12-31 | 13.8 K | |
| Jpmorgan Chase & Co | 2024-12-31 | 13.6 K | |
| Bank Of New York Mellon Corp | 2024-12-31 | 13.1 K | |
| Goldman Sachs Group Inc | 2024-12-31 | 12.3 K | |
| Charles Schwab Investment Management Inc | 2024-12-31 | 11.4 K | |
| Salem Investment Counselors Inc | 2024-12-31 | 11.2 K | |
| Stephens Inc | 2024-12-31 | 10.8 K | |
| Blackrock Inc | 2024-12-31 | 215 K | |
| Vanguard Group Inc | 2024-12-31 | 200.8 K |
Sanara Medtech Historical Income Statement
Sanara Stock Against Markets
Sanara Medtech Corporate Management
| Bill Fitzgerald | Compliance Officer | Profile | |
| Jacob Waldrop | Chief Officer | Profile | |
| Callon Nichols | Director Relations | Profile | |
| Elizabeth Taylor | Chief Officer | Profile | |
| Jane Fore | Chief Officer | Profile | |
| Tricia Matteson | Director Marketing | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanara Medtech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Sanara Stock please use our How to Invest in Sanara Medtech guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sanara Medtech. If investors know Sanara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sanara Medtech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.99) | Revenue Per Share | Quarterly Revenue Growth 0.352 | Return On Assets | Return On Equity |
The market value of Sanara Medtech is measured differently than its book value, which is the value of Sanara that is recorded on the company's balance sheet. Investors also form their own opinion of Sanara Medtech's value that differs from its market value or its book value, called intrinsic value, which is Sanara Medtech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sanara Medtech's market value can be influenced by many factors that don't directly affect Sanara Medtech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sanara Medtech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanara Medtech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sanara Medtech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.